Section
13 articles
Advertisement
India’s semaglutide patent expiry is expected to lead to cheaper weight-loss drugs. Local pharmaceutical companies are preparing to release multiple generic versions. Lower prices could expand access to obesity and diabetes treatment across the country.
The University of Zimbabwe’s Department of Biomedical Sciences has appealed to the public to consider donating their bodies to medical science, saying a shortage of cadavers is affecting the training...
The morning-after pill is now available free of charge at pharmacies across England, according to NHS England. The new service, launched this week, allows women to access emergency contraception...
The Zimbabwe Republic Police (ZRP) is investigating a suspected case of food poisoning that claimed the lives of two children and left 14 others critically ill after a traditional beer ceremony in...
A new medical study has linked the injectable contraceptive Depo-Provera to an increased risk of brain tumors, as more than 1,000 women have filed lawsuits against its manufacturer, Pfizer Inc.,...
The National Health Service (NHS) will begin offering a new long-acting injection to prevent HIV in England and Wales for the first time, bringing the two nations in line with Scotland’s existing...
Zimbabwe has been chosen as one of ten countries worldwide to introduce lenacapavir, a new HIV prevention medicine that provides long-acting protection against new infections. The U.S. Department of...
HARARE – Cimas Medical Aid Society has announced that it will introduce contribution loading on members whose claims are above international standards, effective 1 September 2025. In a statement to...
The City of Harare has urged residents to use larger buckets when flushing toilets to reduce sewer blockages. The directive follows warnings that small containers used during water rationing are...
original article https://www.zbcnews.co.zw/zimbabwe-leads-africas-first-human-trial-of-t-cell-hiv-vaccine/ Zimbabwe has launched Africa’s first human trial of a T-cell HIV vaccine, marking a major...
